CGEN
Price
$1.75
Change
-$0.07 (-3.85%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
170.16M
15 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$21.45
Change
-$0.52 (-2.37%)
Updated
Feb 4, 03:15 PM (EDT)
Capitalization
15.29B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEN vs ROIV

Header iconCGEN vs ROIV Comparison
Open Charts CGEN vs ROIVBanner chart's image
Compugen
Price$1.75
Change-$0.07 (-3.85%)
Volume$14.11K
Capitalization170.16M
Roivant Sciences
Price$21.45
Change-$0.52 (-2.37%)
Volume$1.68K
Capitalization15.29B
CGEN vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
CGEN vs. ROIV commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CGEN: $1.82 vs. ROIV: $21.97)
Brand notoriety: CGEN and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 43% vs. ROIV: 61%
Market capitalization -- CGEN: $170.16M vs. ROIV: $15.29B
CGEN [@Biotechnology] is valued at $170.16M. ROIV’s [@Biotechnology] market capitalization is $15.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 5 bearish.
  • ROIV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CGEN and ROIV are a bad buy in the short-term.

Price Growth

CGEN (@Biotechnology) experienced а -9.90% price change this week, while ROIV (@Biotechnology) price change was -2.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

CGEN is expected to report earnings on Feb 19, 2026.

ROIV is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($15.3B) has a higher market cap than CGEN($170M). CGEN has higher P/E ratio than ROIV: CGEN (64.00) vs ROIV (1.97). CGEN YTD gains are higher at: 18.954 vs. ROIV (1.244). CGEN has higher annual earnings (EBITDA): -32.2M vs. ROIV (-1.14B). ROIV has more cash in the bank: 4.39B vs. CGEN (86.1M). CGEN has less debt than ROIV: CGEN (2.95M) vs ROIV (98.8M). ROIV has higher revenues than CGEN: ROIV (20.3M) vs CGEN (6.9M).
CGENROIVCGEN / ROIV
Capitalization170M15.3B1%
EBITDA-32.2M-1.14B3%
Gain YTD18.9541.2441,523%
P/E Ratio64.001.973,256%
Revenue6.9M20.3M34%
Total Cash86.1M4.39B2%
Total Debt2.95M98.8M3%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
51%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBTP26.03N/A
+0.02%
Invesco 0-5 Yr US TIPS ETF
QBUL23.73-0.06
-0.25%
TrueShares Quarterly Bull Hedge ETF
USPX60.33-0.53
-0.87%
Franklin US Equity Index ETF
MSLC54.84-0.51
-0.91%
Morgan Stanley Pathway Large Cap Eq ETF
ESPO97.98-2.75
-2.73%
VanEck Vdo Gaming and eSprts ETF

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NURPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NURPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
+0.55%
NURPF - CGEN
46%
Loosely correlated
N/A
BDTX - CGEN
43%
Loosely correlated
-0.79%
ASPHF - CGEN
41%
Loosely correlated
N/A
ORMP - CGEN
40%
Loosely correlated
+0.29%
ROIV - CGEN
38%
Loosely correlated
+0.14%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.14%
IMVT - ROIV
59%
Loosely correlated
-1.07%
NUVL - ROIV
50%
Loosely correlated
+2.12%
KYMR - ROIV
49%
Loosely correlated
+2.12%
RVMD - ROIV
48%
Loosely correlated
-1.22%
CRNX - ROIV
48%
Loosely correlated
+1.24%
More